Vol. 59 No. 6 (2020): Acta Oncologica

Articles

• Inequity in palliative care service full utilisation among patients with advanced cancer: a retrospective Cohort study

  Daniela D’Angelo, Marco Di Nitto, Diana Giannarelli, Ileana Croci, Roberto Latina, Anna Marchetti, Caterina Magnani, Chiara Mastroianni, Michela Piredda, Marco Artico, Maria Grazia De Marinis

  620-627

  Published: 2020-06-02

  • PDF

• Comparison between CT and MRI in detection of metastasis of the retroperitoneum in testicular germ cell tumors: a prospective trial

  Marjut Laukka, Susanna Mannisto, Annette Beule, Mauri Kouri, Carl Blomqvist

  660-665

  Published: 2020-06-02

  • PDF

• Frequency of discordance in programmed death-ligand 1 (PD-L1) expression between primary tumors and paired distant metastases in advanced cancers: a systematic review and meta-analysis

  Chia Ching Lee, Yu Yang Soon, Jeffrey Huey Yew Lum, Char Loo Tan, Jeremy Chee Seong Tey

  696-704

  Published: 2020-06-02

  • PDF

• Expectations to Patient-Reported Outcome (PRO) in Oncology – PRO for a purpose, when and how?

  Helle Pappot, Gry Assam Taarnhøj

  Published: 2020-06-02

  • PDF

• Influence of pretreatment with everolimus or sunitinib on the subacute hematotoxicity of 177Lu-DOTATATE PRRT

  Eva Medaer, Chris Verslype, Eric Van Cutsem, Jeroen Dekervel, Paul M. Clement, Kristiaan Nackaerts, Annouschka Laenen, Olivier Gheysens, Karolien Goffin, Sander Jentjens, Koen Van Laere, Christophe M. Deroose

  644-651

  Published: 2020-06-02

  • PDF

• Tumor-associated trypsin inhibitor (TATI) and tumor-associated trypsin-2 (TAT-2) predict outcomes in gastric cancer

  Aaro Kasurinen, Alli Laitinen, Arto Kokkola, Ulf-Håkan Stenman, Camilla Böckelman, Caj Haglund

  681-688

  Published: 2020-06-02

  • PDF

• The impact of cyclin-dependent kinase 4 and 6 inhibitors (CDK4/6i) on the incidence of alopecia in patients with metastatic breast cancer (BC)

  Daniel Eiger, Marcio Wagner, Noam F. Pondé, Melanie S. Nogueira, Laurence Buisseret, Evandro de Azambuja

  723-725

  Published: 2020-06-02

  • PDF

• Analysis of early respiratory-related mortality after radiation therapy of non-small-cell lung cancer: feasibility of automatic data extraction for dose–response studies

  Louise Stervik, Niclas Pettersson, Jonas Scherman, Claus F. Behrens, Crister Ceberg, Silke Engelholm, Kerstin Gunnarsson, Andreas Hallqvist, Jan Nyman, Gitte F. Persson, Mette Pøhl, Isak Wahlstedt, Ivan R. Vogelius, Anna Bäck

  628-635

  Published: 2020-06-02

  • PDF

• Prognostic impact of PD-L1 in oropharyngeal cancer after primary curative radiotherapy and relation to HPV and tobacco smoking

  Jacob K. Lilja-Fischer, Jesper G. Eriksen, Jeanette B. Georgsen, Thao T. Vo, Stine R. Larsen, Jonathan Cheng, Michael Busch-Sørensen, Deepti Aurora-Garg, Torben Steiniche, Jens Overgaard

  666-672

  Published: 2020-06-02

  • PDF

• Implementation of contemporary chemotherapy for patients with metastatic pancreatic ductal adenocarcinoma: a population-based analysis

  Anouk E. J. Latenstein, Tara M. Mackay, Geert-Jan Creemers, Casper H. J. van Eijck, Jan Willem B. de Groot, Nadia Haj Mohammad, Marjolein Y. V. Homs, Hanneke W. M. van Laarhoven, I. Quintus Molenaar, Bert-Jan ten Tije, Judith de Vos-Geelen, Marc G. Besselink, Lydia G. M. van der Geest, Johanna W. Wilmink

  705-712

  Published: 2020-06-02

  • PDF

• Patient-reported outcomes 1 year after oesophageal cancer surgery

  Anna Schandl, Asif Johar, Poorna Anandavadivelan, Karin Vikström, Kalle Mälberg, Pernilla Lagergren

  613-619

  Published: 2020-06-02

  • PDF

• Favorable prognostic impact of Natural Killer cells and T cells in high-grade serous ovarian carcinoma

  Jon Røikjaer Henriksen, Frede Donskov, Marianne Waldstrøm, Anders Jakobsen, Mette Hjortkjaer, Christina Braad Petersen, Karina Dahl Steffensen

  652-659

  Published: 2020-06-02

  • PDF

• Can a machine-learning model improve the prediction of nodal stage after a positive sentinel lymph node biopsy in breast cancer?

  V. Madekivi, P. Boström, A. Karlsson, R. Aaltonen, E. Salminen

  689-695

  Published: 2020-06-02

  • PDF

• Hypocalcemia induced by tyrosine kinase inhibitors: targeted treatment with ‘untargeted’ side effects

  Annika M. A. Berends, Anouk N. A. van der Horst-Schrivers, Sjoukje F. Oosting, Ellen W. Kapiteijn, Jan Willem B. de Groot, Thera P. Links

  726-729

  Published: 2020-06-02

  • PDF

• Elderly gynaecological cancer patients at risk for poor end of life care: a population-based study from the Swedish Register of Palliative Care

  K. Lindemann, L. Martinsson, S. Kaasa, D. Lindquist

  636-643

  Published: 2020-06-02

  • PDF

• CD30 expression and survival in posttransplant lymphoproliferative disorders

  Amelie Kinch, Rose-Marie Amini, Peter Hollander, Daniel Molin, Christer Sundström, Gunilla Enblad

  673-680

  Published: 2020-06-02

  • PDF

• Secondary analyses of the randomized phase III Stop&Go study: efficacy of second-line intermittent versus continuous chemotherapy in HER2-negative advanced breast cancer

  Anouk K. M. Claessens, Frans L. G. Erdkamp, Marta Lopez-Yurda, Jeanette M. Bouma, Jeany M. Rademaker-Lakhai, Aafke H. Honkoop, Hiltje de Graaf, Vivianne C. G. Tjan-Heijnen, Monique E. M. M. Bos

  713-722

  Published: 2020-06-02

  • PDF